Yahoo Web Search

  1. Company News For Aug 6, 2019

    Zacks via Yahoo FinanceAug 06 14:16 PM

    Allergan plc's AGN shares dipped 0.2% after the company reported second quarter 2019 earnings per share of $4.38, lower than $4.42 a share in the year ago quarter Energizer Holdings ...

  2. Allergan (AGN) Q2 Earnings & Sales Top, '19 Sales View Up

    Zacks via Yahoo FinanceAug 06 14:19 PM

    Allergan plc’s AGN second-quarter adjusted earnings came in at $4.38 per share, which beat the Zacks Consensus Estimate of $4.34 and came within the guided range of $4.20 and $4.40 ...

  3. Investors in Allergan plc AGN need to pay close attention to the stock based on moves in the options market lately. Options with high levels of implied volatility suggest that ...

  4. Allergan Plc, which is being bought by AbbVie Inc for $63 billion, beat quarterly profit estimates and raised its 2019 revenue forecast on Tuesday, helped by demand for its dry ...

  5. Allergan (AGN) Surpasses Q2 Earnings and Revenue Estimates

    Zacks via Yahoo FinanceAug 06 12:55 PM

    Allergan (AGN) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.34 per share. This quarterly report represents an earnings surprise of 0.92% ...

  6. Allergan (AGN) Gains As Market Dips: What You Should Know

    Zacks via Yahoo FinanceAug 02 21:45 PM

    Heading into today, shares of the Botox maker had lost 5.13% over the past month, lagging the Medical sector's loss of 1.96% and the S&P 500's loss of 0.27% in that time. Meanwhile, our latest ...

  7. Allergan (AGN), which belongs to the Zacks Medical - Generic Drugs industry, could be a great candidate to consider. When looking at the last two reports, this Botox maker has recorded ...

  8. This week Allergan AGN and Denmark's Novo Nordisk NVO announced second quarter results. The European Commission granted approval to AbbVie's ABBV chronic hepatitis C drug Maviret and ...

  9. Can Value Investors Consider Allergan (AGN) a Worthy Pick?

    Zacks via Yahoo FinanceAug 13 13:45 PM

    Value investing is easily one of the most popular ways to find great stocks in any market environment. One way to find these companies is by looking at several key metrics and financial ratios ...

  10. Will Cost Control Help Teva (TEVA) Beat on Q2 Earnings?

    Zacks via Yahoo FinanceAug 05 13:07 PM

    We expect Teva Pharmaceutical Industries Limited TEVA to beat estimates when it reports second-quarter 2019 results on Aug 7, before market open. In the last reported quarter, the company delivered a positive earnings surprise of 3.45%.